{"ticker": {"uuid": "e020bcbe-4ea0-4634-866d-6c197034846f", "symbol": "4507", "name": "Shionogi & Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Shionogi & Co (4507) Q1 2026 earnings summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTFBkU0ZKaDhHMDJJaEZWOHBrb1R0ZUdCUlR2UFYwbTN0N2RxbHFGMk8zVmpHSDJIWUMwRGlKdUpEQlZ0ZlJhU05idjhZMi1VVGFPOFdacVJ0ZTkzTkJMX0twam15LTc3NDZrUi1F?oc=5", "source_name": "Quartr", "published_at": "2026-07-06T19:44:58+00:00", "published_display": "06 Jul 2026 19:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Xocova from Shionogi - COVID-19 antiviral that targets Japan\u2019s home market first", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOOFA5by1Ud2pqcGYyZkFQcWRPUG5ubzFYVTNwT2pBNWZPMWRWS3NnYTdzMldBcHRsODl5Z3hCbnRwZ1IxMV8tMTVMX0VQam43clVDNzFSZ0hvOUFuRDNxQjZGNUwzWkdueVhoZGVja05qaXNrWmFNUHJqU2FzZGFrUUFLTVpVS0VOTU9rMno0bzA2Rzh1SFlhaTg1ZGtUalZ1RU1sU2dhbEpxM253Q0czcUdzdGZWdjdZamtsb25jTjVYeGp6WGdB?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-05T02:51:01+00:00", "published_display": "05 Jul 2026 02:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi stock holds the line. Focus stays on the company", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNWUpyeGtUQXEyVnc0V3REekFFWXBvU3BKaEJIdFJlVk4yeDNtb1Z6TWJKTU1hVVRzdW44WDlzVHdpdnJQbkRPcWU5eEhWLVVnaE1odXhjQUY3dHFNZDVNWFRURjJzejhpMGszX0k3eGlScDlVSVF0V01Rd2U1WkZnM05ra2Y2emVpMDFFOTdKNHBnZ0dQenNfQmtUZV9OWml5VUFXOHJuRDJ0VFlGVHhYQVhOOGJUUQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T14:44:54+00:00", "published_display": "04 Jul 2026 14:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi focuses on long-term growth as global pharma competition intensifies", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQTjI1UHFsZW1HM3ZmR2V5YlFHRklSaFozQU1hNVVNYWNFdkFoMGlseVU4T1pGNVp4NFRVSXc2ZjVlYmQyTjZWTS1PWVlqYlNRYmtuMmx5WV8tb1dGM3pyUmxkV19fMXUxZlZyLWlZMlZtUDh6UnBoRGE3YTljSFRDM1lSNjBxZFZBN1pXaFpyS2dYdDJlUGJlaWNHaE4zWTRTNXRxYm1vYjdUSlA0TUljVUhtR0QzdlBYUzJxQkl5RUpDQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T11:05:14+00:00", "published_display": "04 Jul 2026 11:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi\u2019s Olorofim Phase 3 Success And XOCOVA Expansion Might Change The Case For Investing In Shionogi (TSE:4507)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi (TSE:4507) Infectious Disease Progress Keeps Valuation Questions In Play", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxObzI2blZzSEw1RUJBSF90TUwtQ2Jqa1M0MG5oRnp5amM0QjU5b040akY0dlJ3cEM3TlNTLVRmdV9naWpWUlFXRW5oamJScmtVMFlnRUxBM3lZMDBwNERWcjVSWjlLWXo4bUo2RFVFekloOVZNOVA2Q2k4eTc4Ry1zUmZuTUxvZE9yT3hCcHdCUGdJd0hYWnRMeGxoR0I4Skk3M0Niek41SnIyeWxnUmx6Vno1UGMzNnJzNkVMYlRhZUE0ZnY4Q1BJVHdvSXZUNG9tVFNaRV9fSHBvdjQwbWRj0gHkAUFVX3lxTE1YaXNSaU56elc3ZVNJUXJBMVhWOEREeFNxSFFINGpSdmNGeVJOS2EtbE9VT3FYaENjTDFteUdPYkJpQUQ3cXlwSUV0S2U0S3RkOGxBZV9iRERKNnlWcGdjZ3hiUnVHRUtUZXN5U3JSOVBmMXoycjFmaF8wVzZQS3l2ZE5JMTZQU29JN29kcnJNd1ZjWWZvT2Z5NXo0MWpXT0RIOFlTbWlCR0gtS1B2U1pFTEkzN1E2MFVfZWlYaHQ1U0tSYlVVQmU3VmV0VkpZUTZfYS1OdUY1aUdxS0dsVEdmOTBkUw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi (TSE:4507) Valuation Check As XOCOVA Wins First US FDA Approval For COVID 19 Post Exposure Prophylaxis", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQVnEteUZEVTA2OE55czFrMG00MUZnME1jRnBZeWVrblE3cU4zbVVRbFdhQkRDQnk5cGprOEY2YjNXZ253VHpGNXpISjBBdXZuUnlUTFpTb3NtUnRNVFNaWHRvb2VIem5CdFU4VHVzQlFDSUNPZWVRUUxuY3JvSnZzOWRDdDlWdmNLU1RPb1ZvZXRZNWZvVnRRV3ptajNrS2xrLXlEMA?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Shionogi & Co., Ltd. (TSE:4507) Annual Results Are Out And Analysts Have Published New Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPNDNiVk5Ua1oxZzRCd3JWSmVzN2dMZlMzbTQ0MDlmQmtVcDZnMnZkUGxSbi1IcDFOa1ZGQVNWOUlCR2FJYXFyT2xiUlJxSEhvbVBYUnRhb0ExTUdNZkZlczVzUTZESkJEM1pzTEltUDItRVpUdjljdFg5eEM5R3dmZlVwMkJKQmNXUEhqUFk3WkVWUXNkX1liV3ZzbldIdHRqTmhXc0JZa3JOODN5V084QmI2Vk4wcDgtVWhFWkt4QjlFRkFKSmRQRXVrenBheHZNdWVDWlIybkJzZVVCODk00gHkAUFVX3lxTE5sNm54YnF4ZE1jR3RFaG0xUWZTMlZiR3dzTVVhcTJyb3lwbXM3eWJCQjlYSjFqM01nU0gtTkI1bk9EV0JYZjN1dGw1WUNzeXNwbWdkYUk3QWJ4NFVlUUhPUkx0N0RCeFVyZlg0ZDE4VmRwZDZselllSm4yYVBKQ3FMNHd1b1YtWkFxdmtwc0FlbjQ2Y1JHTGdxMTYzQ2pLRnRqdU8wUFdWOTdWZWNtNjdqVlNhZm9SVE5HNlY0Ty1nR0pXU0JsTUlOc3p2S1hwa19NN3RwSG0zMm5qem5UVWlWZTBPOA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi Selected as a \u201cDX Stock 2026\u201d\uff5c \u5869\u91ce\u7fa9\u88fd\u85ac", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE0temptZzJuU0FlcmFFY2c2LU4zNS0tNG9saXM1bE1ycHpLZjVhUExWNVgwb1JuM1djVDZRNkdzeEVuQVRIcV9tNWVrVm8zOWhkZ2U4bGUtcEQxaUI3SG1qeEtWaERjX2xqc0F6U3RB?oc=5", "source_name": "Shionogi Inc.", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPOERQYzcwMWQ0bEoxTDhsN1dwRkZVNlQxaFcwVk9ZS19LYThiMTJUeUZxX1JfcjY4eVc4U3VVMmN3dl96eGxUYjk0LTNQS0o0ZnRvRG1GTUVHRDkzeWVHZC11Slg5MFd4clZNSENBd1N2Q2J1emJGS2dieERuQVp1azRqWFliSXo2UV9sTEE3Rmk0bHZxR09TNndxTlJPTXMxekEzcWREZU1iVHBJWHJldWdCOGltdw?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOQjRsbUpWS1hKMzk4aXZReFc3XzFIZ0huNy1IVVZ4VG0wOFROc21LdW1nZnNvLTlVclhibUZqQlZEMnFiNmtleFhwZU5TRVZRTFlpeDk5NmVSLUcyMnlvX05PT0N6b18xazB2bm1yendpbHEzWk9XWWJ2aFFyVi1pZjU2NVhaSGV4VGhJRW9vUHJaZzRnVmVJcXFoOGgxeDhDSFdZV2VtN0M0c3Q1c3UxNkQ5V3NYSklMbnk4NXBiOA?oc=5", "source_name": "Reuters", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi & Co., Ltd. acquired 54.84% stake in Torii Pharmaceutical Co., Ltd. from Japan Tobacco Inc..", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPUmZSTkJTeTdPaVNCMkc1MzF5X1dZY1prX1FZV21DMXUtcTBLakNaNmNwVHJJOEYzNzBpNnFKd0pScjdQUVdfSjdvRFVyOVpUMV9pRnpkUm40cGpqTEc5VFVSTEhxVzIwdDMwcmtGU2xmcDVobG5CNFNkdUdpNWQ1Ql9QTkJjNlJtWFdwRTN5UEpYbHduNi0yZkVEOGw1dUxoaExDMEJmU3ZVbThKbE9VR1BScUd5Y3MxME9IWjBCcUhZamZFelVJckY2bGZIcjlYR2Z4VTFveDE5SEU?oc=5", "source_name": "marketscreener.com", "published_at": "2025-08-31T07:00:00+00:00", "published_display": "31 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi to acquire Japan Tobacco pharma companies for $1.1B", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOMEVRdlFpMUNnUFhzZ1ZiSGdJbWFrMll6QkhEOWNyTUNmdEV6MS05bmVVdjl6T2Z0dE9aM3ZOaHNPWmRTRm9Za1c2NlRYYmFzcXFrRU82MkpsTlBBcWZRbEU2SWRpZ2VtRjRfM3B6cFVqNDgzdGV3NzEtTlNLNzZSeTVsSzBxbWpXZF9qSDhnM0lURGRfYjJvYkloMzF0SXdi?oc=5", "source_name": "BioWorld News", "published_at": "2025-05-08T07:00:00+00:00", "published_display": "08 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQNWFFd1AtcEdBQTBjSEpIdHBNdmtJaXJ4QkJZWHZMcW9ZbXg4OWhMSVpjM0UwZ1NFR0tfRWt3Y2t2R1ZldlJkcXQxX1dsdjA0QVdNZ1JhRDNiMlE0ZF96ZWViN0o2VG1tMGZKMW5ORUdnazJOR1RTYk9mdjJONmJyajBzTnptdXVScWQtNnhrRVVmVzU4M2pXMGNtejRLaXdFS21MZURQQjhkcHlocmd5Mk5WZXJZRUZYdWxvX0cyeVNYaEh0aDk3ZGN4QldJVVE?oc=5", "source_name": "Reuters", "published_at": "2025-05-07T07:00:00+00:00", "published_display": "07 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi sinks in Tokyo trade after panel again delays COVID pill approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPT3JXWV9qVm0wZzczMEF3VFBoc0NMdzNlbnpWU1JoZUhLMExEQWxkQTdVbVZKUkxUWFROY0JVaXZuT3hCQi1CbUhJaXBRS21UVjF1dDNsQlFzNlBfNDNxNkVSSEM2N3kzVHMtSTMxQ3BUd2VpXzl6bGZuUmZWTFg4QlFOa0hKc0VEYTJ4elk1R1Y3ZHhJQU5xMGVMVW8yQXJGYlI1MTlxZGtNSDlKeUIxT2ZGYXZxSVhZRV8waTlRTzBBLWhsZXZac0RXSWw1WG8tVk5yMVZrZw?oc=5", "source_name": "Reuters", "published_at": "2022-07-21T07:00:00+00:00", "published_display": "21 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi Shares Slump After Japan Panel Rejects Emergency Approval for its Covid-19 Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOZ0Q4VkdxckVrYk95dnBwOHVMSTlnWWhhYzNOaXZqUmdVYWFhQnY0ak9KNFNvZWVzZ3JEYkItS1R1c1VpM08xY0JYSWtKRHNjdUdYaGtBdnlIOS1MN0VlNkVYeGk1WmpCTXg3bTIxUVUwbk45N0lOUHRSNnZnV01KZTVOUjR3U2FMT2lEeXJDa01aWVhfbUd1UjNPQWUzUlVHUlB3TTMyblZCSjBmZXhWRV90VDkxSlhhQk1SUnlyZkNpcFRWUVEtazlkdWlVNzA?oc=5", "source_name": "WSJ", "published_at": "2022-07-20T07:00:00+00:00", "published_display": "20 Jul 2022 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi says continuing Vietnam COVID projects after partner scandals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1UdkxmamcycjEzUmYtME1tNWdHQWtDUEhsUXNkeEtUWWZJQzBjdlYzdzZsQTMzWjg2OVh6QkZJc0paQmhlYlF0RGx3NzFGSFlPSjJoN3pR?oc=5", "source_name": "\u671d\u65e5\u65b0\u805e", "published_at": "2022-06-10T07:00:00+00:00", "published_display": "10 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi COVID pill: Investors flee drugmaker on news of birth defect risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdmNIY2d6NzU5OGkzQkNqTVFHbUdFdDNJRXFJQjdJT0ZKcVVnRTdoWktRTWNYWVlxX1V5eko0N0ZiOW0ya1RfSm56TkJfTW1YTEVBVzBfaVYtNHhDTzZrVXRvRkFmeEtGY2xXanpvbV9rN3dUdVh3VFlmd3E1a0gzY2lVa01VdTVyOG5Lb0tFNlROYXM4NnBDU2dqa0ItTkRSclo2Z0k4Y0FLWklSVUw3bEtfbFNNZGM?oc=5", "source_name": "Fortune", "published_at": "2022-04-13T07:00:00+00:00", "published_display": "13 Apr 2022 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE80U2ltUFd0NHd6LUg3cVlwdlJfbVRZMU1Ed0s1NVJ1SUo3OThfaTlILTJGbzhIX0NieFhsdVJkRUtpanBuMGkwY1JKVmFYSXZHWm15QWMtODdvZWFE?oc=5", "source_name": "MarketBeat", "published_at": "2019-09-24T21:36:11+00:00", "published_display": "24 Sep 2019 21:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Shionogi & Co (4507) Q1 2026 earnings summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTFBkU0ZKaDhHMDJJaEZWOHBrb1R0ZUdCUlR2UFYwbTN0N2RxbHFGMk8zVmpHSDJIWUMwRGlKdUpEQlZ0ZlJhU05idjhZMi1VVGFPOFdacVJ0ZTkzTkJMX0twam15LTc3NDZrUi1F?oc=5", "source_name": "Quartr", "published_at": "2026-07-06T19:44:58+00:00", "published_display": "06 Jul 2026 19:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Xocova from Shionogi - COVID-19 antiviral that targets Japan\u2019s home market first", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOOFA5by1Ud2pqcGYyZkFQcWRPUG5ubzFYVTNwT2pBNWZPMWRWS3NnYTdzMldBcHRsODl5Z3hCbnRwZ1IxMV8tMTVMX0VQam43clVDNzFSZ0hvOUFuRDNxQjZGNUwzWkdueVhoZGVja05qaXNrWmFNUHJqU2FzZGFrUUFLTVpVS0VOTU9rMno0bzA2Rzh1SFlhaTg1ZGtUalZ1RU1sU2dhbEpxM253Q0czcUdzdGZWdjdZamtsb25jTjVYeGp6WGdB?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-05T02:51:01+00:00", "published_display": "05 Jul 2026 02:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi stock holds the line. Focus stays on the company", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNWUpyeGtUQXEyVnc0V3REekFFWXBvU3BKaEJIdFJlVk4yeDNtb1Z6TWJKTU1hVVRzdW44WDlzVHdpdnJQbkRPcWU5eEhWLVVnaE1odXhjQUY3dHFNZDVNWFRURjJzejhpMGszX0k3eGlScDlVSVF0V01Rd2U1WkZnM05ra2Y2emVpMDFFOTdKNHBnZ0dQenNfQmtUZV9OWml5VUFXOHJuRDJ0VFlGVHhYQVhOOGJUUQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T14:44:54+00:00", "published_display": "04 Jul 2026 14:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi focuses on long-term growth as global pharma competition intensifies", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQTjI1UHFsZW1HM3ZmR2V5YlFHRklSaFozQU1hNVVNYWNFdkFoMGlseVU4T1pGNVp4NFRVSXc2ZjVlYmQyTjZWTS1PWVlqYlNRYmtuMmx5WV8tb1dGM3pyUmxkV19fMXUxZlZyLWlZMlZtUDh6UnBoRGE3YTljSFRDM1lSNjBxZFZBN1pXaFpyS2dYdDJlUGJlaWNHaE4zWTRTNXRxYm1vYjdUSlA0TUljVUhtR0QzdlBYUzJxQkl5RUpDQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T11:05:14+00:00", "published_display": "04 Jul 2026 11:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi\u2019s Olorofim Phase 3 Success And XOCOVA Expansion Might Change The Case For Investing In Shionogi (TSE:4507)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi (TSE:4507) Infectious Disease Progress Keeps Valuation Questions In Play", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi (TSE:4507) Valuation Check As XOCOVA Wins First US FDA Approval For COVID 19 Post Exposure Prophylaxis", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQVnEteUZEVTA2OE55czFrMG00MUZnME1jRnBZeWVrblE3cU4zbVVRbFdhQkRDQnk5cGprOEY2YjNXZ253VHpGNXpISjBBdXZuUnlUTFpTb3NtUnRNVFNaWHRvb2VIem5CdFU4VHVzQlFDSUNPZWVRUUxuY3JvSnZzOWRDdDlWdmNLU1RPb1ZvZXRZNWZvVnRRV3ptajNrS2xrLXlEMA?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Shionogi & Co., Ltd. (TSE:4507) Annual Results Are Out And Analysts Have Published New Forecasts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi Selected as a \u201cDX Stock 2026\u201d\uff5c \u5869\u91ce\u7fa9\u88fd\u85ac", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE0temptZzJuU0FlcmFFY2c2LU4zNS0tNG9saXM1bE1ycHpLZjVhUExWNVgwb1JuM1djVDZRNkdzeEVuQVRIcV9tNWVrVm8zOWhkZ2U4bGUtcEQxaUI3SG1qeEtWaERjX2xqc0F6U3RB?oc=5", "source_name": "Shionogi Inc.", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPOERQYzcwMWQ0bEoxTDhsN1dwRkZVNlQxaFcwVk9ZS19LYThiMTJUeUZxX1JfcjY4eVc4U3VVMmN3dl96eGxUYjk0LTNQS0o0ZnRvRG1GTUVHRDkzeWVHZC11Slg5MFd4clZNSENBd1N2Q2J1emJGS2dieERuQVp1azRqWFliSXo2UV9sTEE3Rmk0bHZxR09TNndxTlJPTXMxekEzcWREZU1iVHBJWHJldWdCOGltdw?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOQjRsbUpWS1hKMzk4aXZReFc3XzFIZ0huNy1IVVZ4VG0wOFROc21LdW1nZnNvLTlVclhibUZqQlZEMnFiNmtleFhwZU5TRVZRTFlpeDk5NmVSLUcyMnlvX05PT0N6b18xazB2bm1yendpbHEzWk9XWWJ2aFFyVi1pZjU2NVhaSGV4VGhJRW9vUHJaZzRnVmVJcXFoOGgxeDhDSFdZV2VtN0M0c3Q1c3UxNkQ5V3NYSklMbnk4NXBiOA?oc=5", "source_name": "Reuters", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi & Co., Ltd. acquired 54.84% stake in Torii Pharmaceutical Co., Ltd. from Japan Tobacco Inc..", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPUmZSTkJTeTdPaVNCMkc1MzF5X1dZY1prX1FZV21DMXUtcTBLakNaNmNwVHJJOEYzNzBpNnFKd0pScjdQUVdfSjdvRFVyOVpUMV9pRnpkUm40cGpqTEc5VFVSTEhxVzIwdDMwcmtGU2xmcDVobG5CNFNkdUdpNWQ1Ql9QTkJjNlJtWFdwRTN5UEpYbHduNi0yZkVEOGw1dUxoaExDMEJmU3ZVbThKbE9VR1BScUd5Y3MxME9IWjBCcUhZamZFelVJckY2bGZIcjlYR2Z4VTFveDE5SEU?oc=5", "source_name": "marketscreener.com", "published_at": "2025-08-31T07:00:00+00:00", "published_display": "31 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi to acquire Japan Tobacco pharma companies for $1.1B", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOMEVRdlFpMUNnUFhzZ1ZiSGdJbWFrMll6QkhEOWNyTUNmdEV6MS05bmVVdjl6T2Z0dE9aM3ZOaHNPWmRTRm9Za1c2NlRYYmFzcXFrRU82MkpsTlBBcWZRbEU2SWRpZ2VtRjRfM3B6cFVqNDgzdGV3NzEtTlNLNzZSeTVsSzBxbWpXZF9qSDhnM0lURGRfYjJvYkloMzF0SXdi?oc=5", "source_name": "BioWorld News", "published_at": "2025-05-08T07:00:00+00:00", "published_display": "08 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQNWFFd1AtcEdBQTBjSEpIdHBNdmtJaXJ4QkJZWHZMcW9ZbXg4OWhMSVpjM0UwZ1NFR0tfRWt3Y2t2R1ZldlJkcXQxX1dsdjA0QVdNZ1JhRDNiMlE0ZF96ZWViN0o2VG1tMGZKMW5ORUdnazJOR1RTYk9mdjJONmJyajBzTnptdXVScWQtNnhrRVVmVzU4M2pXMGNtejRLaXdFS21MZURQQjhkcHlocmd5Mk5WZXJZRUZYdWxvX0cyeVNYaEh0aDk3ZGN4QldJVVE?oc=5", "source_name": "Reuters", "published_at": "2025-05-07T07:00:00+00:00", "published_display": "07 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi sinks in Tokyo trade after panel again delays COVID pill approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPT3JXWV9qVm0wZzczMEF3VFBoc0NMdzNlbnpWU1JoZUhLMExEQWxkQTdVbVZKUkxUWFROY0JVaXZuT3hCQi1CbUhJaXBRS21UVjF1dDNsQlFzNlBfNDNxNkVSSEM2N3kzVHMtSTMxQ3BUd2VpXzl6bGZuUmZWTFg4QlFOa0hKc0VEYTJ4elk1R1Y3ZHhJQU5xMGVMVW8yQXJGYlI1MTlxZGtNSDlKeUIxT2ZGYXZxSVhZRV8waTlRTzBBLWhsZXZac0RXSWw1WG8tVk5yMVZrZw?oc=5", "source_name": "Reuters", "published_at": "2022-07-21T07:00:00+00:00", "published_display": "21 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi Shares Slump After Japan Panel Rejects Emergency Approval for its Covid-19 Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOZ0Q4VkdxckVrYk95dnBwOHVMSTlnWWhhYzNOaXZqUmdVYWFhQnY0ak9KNFNvZWVzZ3JEYkItS1R1c1VpM08xY0JYSWtKRHNjdUdYaGtBdnlIOS1MN0VlNkVYeGk1WmpCTXg3bTIxUVUwbk45N0lOUHRSNnZnV01KZTVOUjR3U2FMT2lEeXJDa01aWVhfbUd1UjNPQWUzUlVHUlB3TTMyblZCSjBmZXhWRV90VDkxSlhhQk1SUnlyZkNpcFRWUVEtazlkdWlVNzA?oc=5", "source_name": "WSJ", "published_at": "2022-07-20T07:00:00+00:00", "published_display": "20 Jul 2022 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi says continuing Vietnam COVID projects after partner scandals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1UdkxmamcycjEzUmYtME1tNWdHQWtDUEhsUXNkeEtUWWZJQzBjdlYzdzZsQTMzWjg2OVh6QkZJc0paQmhlYlF0RGx3NzFGSFlPSjJoN3pR?oc=5", "source_name": "\u671d\u65e5\u65b0\u805e", "published_at": "2022-06-10T07:00:00+00:00", "published_display": "10 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi COVID pill: Investors flee drugmaker on news of birth defect risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdmNIY2d6NzU5OGkzQkNqTVFHbUdFdDNJRXFJQjdJT0ZKcVVnRTdoWktRTWNYWVlxX1V5eko0N0ZiOW0ya1RfSm56TkJfTW1YTEVBVzBfaVYtNHhDTzZrVXRvRkFmeEtGY2xXanpvbV9rN3dUdVh3VFlmd3E1a0gzY2lVa01VdTVyOG5Lb0tFNlROYXM4NnBDU2dqa0ItTkRSclo2Z0k4Y0FLWklSVUw3bEtfbFNNZGM?oc=5", "source_name": "Fortune", "published_at": "2022-04-13T07:00:00+00:00", "published_display": "13 Apr 2022 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE80U2ltUFd0NHd6LUg3cVlwdlJfbVRZMU1Ed0s1NVJ1SUo3OThfaTlILTJGbzhIX0NieFhsdVJkRUtpanBuMGkwY1JKVmFYSXZHWm15QWMtODdvZWFE?oc=5", "source_name": "MarketBeat", "published_at": "2019-09-24T21:36:11+00:00", "published_display": "24 Sep 2019 21:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 73, "total_relevant": 19, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 13, "score": 51, "total": 19, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 6.4, "count": 11}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.35, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 2.0, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 2832.5, "latest_week": "2026-07-10", "one_week_move": -1.3, "four_week_move": 2.1, "twelve_week_move": -12.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.205459, "market_dynamics_buy_signal": false, "relative_strength": -24.32808, "fair_value_gap": 17.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.1327, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.3% over one week, +2.1% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Reuters", "count": 3}, {"label": "Quartr", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Shionogi Inc.", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 19}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Regulatory and legal", "count": 3}, {"label": "Deals and strategy", "count": 3}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "19", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.3% over one week, +2.1% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Shionogi & Co (4507) Q1 2026 earnings summary"}], "updated_at": "2026-07-17T11:23:13.303912+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}